Making Treatment Decisions

NCCN helps your doctors stay well-informed; we believe you should be, too.

The NCCN Treatment Summaries for People with Cancer™ (listed below) are designed to give patients a better understanding of cancer so they can work with their health care providers to achieve longer and better-quality lives.

The NCCN Treatment Summaries are based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™)— the treatment recommendations most widely used by oncologists and other cancer care providers in the U.S. and the world. The NCCN Guidelines™ combine the best available medical evidence with expert experience on 97% of the cancers that affect people and are continually updated. Even if your doctor does not work at an NCCN Member Institution, there is a good chance that he or she consults the NCCN Guidelines for information on diagnosing, treating, and following up patients with cancer.

NCCN Treatment Summaries below translate the information that doctors use, to help you and your family understand your treatment options, discuss them with your health care team, and make cancer care decisions that are right for you.

Breast Cancer

Breast cancer is the most frequently diagnosed cancer in U.S. women, but the complexity of the disease means that no one treatment will be right for everyone.

Breast Cancer Overview
Lobular Carcinoma in Situ (LCIS)
Ductal Carcinoma in Situ (DCIS)
Breast Cancer Stages I, II, and III
Breast Cancer Stage IV
Inflammatory Breast Cancer
HER2 Testing: Summary for Breast Cancer Patients

Colon and Rectal Cancers

NCCN Treatment Summaries on colon and rectal cancers, the third most frequently diagnosed cancer in men and women in the U.S., can help patients understand their cancer and the best available treatments.

Colorectal Cancer Overview
Colon Cancer Stages 0, I, II, and III
Rectal Cancer Stages 0, I, II, and III
Colorectal Cancer Stage IV

Kidney Cancer

No single kidney cancer treatment is right for everyone. The NCCN treatment summaries help patients understand the best available treatments for their stage of kidney cancer.

Kidney Cancer Overview
Early-Stage Kidney Cancer
Advanced Kidney Cancer

Liver Cancer

Cancer that starts in the liver is called primary liver cancer and differs from cancer that spreads to the liver from somewhere else. The NCCN treatment summaries help patients understand more about this difficult disease.

Primary Liver Cancer Overview
Early-Stage Liver Cancer
Advanced Primary Liver Cancer

Lung Cancer

Lung cancer, the most frequently diagnosed cancer in the U. S., is divided into small cell lung cancer and non-small cell lung cancer.

Lung Cancer Overview
Small Cell Lung Cancer
Early Stage Non-Small Cell Lung Cancer
Late Stage Non-Small Cell Lung Cancer

Myelodysplastic Syndromes (MDS)

Myelodysplastic syndromes (MDS) are more common among people 70 years and older but can also affect younger people.

Myelodysplastic Syndromes

Myeloma

Dramatic advances in the treatment of multiple myeloma in the past several years have given many patients an improved outlook.

Multiple Myeloma
Plasmacytoma

Non-Hodgkin’s Lymphomas (NHL)

Non-Hodgkin’s lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, which is part of the immune system.

Non-Hodgkin’s Lymphomas (NHL) Overview
CLL-SLL/Non-Hodgkin’s Lymphoma
DLBCL/Non-Hodgkin’s Lymphoma
Follicular Lymphoma/Non-Hodgkin’s Lymphoma

Prostate Cancer

Prostate cancer is the most common cancer in men, but immediate treatment may not be the right answer for everyone with this disease. See the NCCN treatment summaries for more information.

Prostate Cancer Overview
Localized Prostate Cancer
Advanced Prostate Cancer

Search:

Browse by Category:

Viewing:

- All -

Displaying 1 - 10 of 28

« Previous Page | Next Page »

Go to page:

Breast Cancer - Inflammatory
Breast cancer is the most frequently diagnosed cancer in U.S. women. Inflammatory breast cancer is a rare form of invasive breast cancer that tends to grow more quickly than other invasive breast cancers. This treatment summary, which is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), helps patients understand the best available treatments for inflammatory breast cancer, so they can discuss them with their doctors.

Breast Cancer - Lobular Carcinoma in Situ (LCIS)
Lobular carcinoma in situ (LCIS) is a precancerous condition in which abnormal cells are found in the lobules in the breast, but studies have shown that LCIS increases risk for future breast cancer. This patient summary, based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), will help women understand LCIS so they can work with their doctor to decide on the best treatment plan for them.

Breast Cancer: Noninvasive - Ductal Carcinoma In Situ (DCIS)
Breast cancer is the most frequently diagnosed cancer in U.S. women. This patient summary, which is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) can help women who’ve been diagnosed with ductal carcinoma in situ (DCIS), which is considered a noninvasive breast cancer, understand the best available treatments, so they can discuss them with their doctors.

Breast Cancer - Disease Overview
Breast cancer is the most frequently diagnosed cancer in U.S. women. This overview of breast cancer as a whole, which is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), helps patients understand more about disease, including diagnosis, treatment options, and follow-up after cancer treatment.

Breast Cancer - Stage I, II, and III
Breast cancer is the most frequently diagnosed cancer in U.S. women. Stage I, II, and III breast cancers are known as invasive cancers. This patient summary, which is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), will help you understand the best available treatments for stage I, II or III cancer.

Breast Cancer – Stage IV
Breast cancer is the most frequently diagnosed cancer in U.S. women. Patients diagnosed with stage IV (also called metastatic) breast cancer probably have many questions and concerns about treatment. This treatment summary, which is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), helps patients understand the best available treatments for stage IV breast cancer, so they can discuss them with their doctors.

Colon and Rectal Cancer - Stage IV
Patients diagnosed with colon cancer, the third most frequently diagnosed cancer in men and women in the U.S., probably have many questions and concerns about treatment. This patient summary, which is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™),helps patients understand the best available treatments for colon cancer so they can work with their doctor to decide on the best available treatment.

Colon and Rectal Cancer Overview
Patients diagnosed with colorectal cancer, the third most frequently diagnosed cancer in men and women in the U.S., probably have many questions and concerns about treatment. This patient summary, which is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) helps patients understand the best available treatments for colorectal cancer so they can work with their doctor to decide on the best available treatment.

Colon Cancer – Stage 0, I, II and III
If you have been diagnosed with colon cancer, you probably have many questions and concerns about treatment. This patient summary, which is based on the NCCN Clinical Practice Guidelines in Oncology™, will help you understand the best available treatments for colon cancer. Talk to your doctor about these therapies so that together you can decide on a treatment plan that is right for you.

HER2 Testing: Summary for Breast Cancer Patients
HER2 Testing: Summary for Breast Cancer Patients™ was developed by the Research Advocacy Network and the National Comprehensive Cancer Network® (NCCN®) and is based on an NCCN Task Force report. The NCCN Task Force concluded that "accurate assignment of the HER2 status of invasive breast cancer is essential to clinical decision making in the treatment of breast cancer in both early stage and metastatic settings."